| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.09 | 0.005 |